AzTrials
AzTrials

Postoperative IleusNCT04090073

Electroacupuncture Combined With Fast-track Perioperative Program for Laparoscopic Colorectal Surgery

A study testing Electroacupuncture and Fast-track Perioperative program in people with Postoperative Ileus, run by Chinese University of Hong Kong at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: The investigators' previous study demonstrated that electroacupuncture (EA) reduces the duration of postoperative ileus and hospital stay after laparoscopic colorectal surgery within a traditional perioperative care setting. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Postoperative Ileus
What is being tested?
Electroacupuncture and Fast-track Perioperative program
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
72 participants
Where
1 siteChina
Study dates
1 Oct 2019to Oct 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Consecutive patients undergoing elective laparoscopic resection of colonic and upper rectal cancer (adenocarcinoma of the colorectum of which the lowest margin of the tumor is located >12 cm from the anal verge as measured by rigid sigmoidoscopy)
  • Age of patients >18 years
  • Those with American Society of Anesthesiologists (ASA) grading I-III
  • Those with no cognitive impairment (Mini Mental State Examination score 24 out of 30)
  • Those with no severe physical disability
  • Those who require no assistance with the activities of daily living
  • Informed consent available

Who cannot join

  • Patients undergoing laparoscopic low anterior resection with total mesorectal excision, abdominoperineal resection, or total/proctocolectomy; those with planned stoma creation
  • Those undergoing simultaneous laparoscopic resection of colorectal cancer and other coexisting intraabdominal diseases
  • Those undergoing laparoscopic resection of colorectal cancer with en bloc resection of surrounding organs
  • Those who developed intraoperative problems or complications that required conversion
  • Those undergoing emergency surgery
  • Those with evidence of peritoneal carcinomatosis
Show all 12Show fewer
  • Those with previous history of midline laparotomy
  • Those who are expected to receive epidural opioids for postoperative pain management
  • Those who are pregnant
  • Those with cardiac pacemaker
  • Those with coagulopathy
  • Those who are allergic to the acupuncture needles

Trial locations and contacts

1 site in 1 country.

China1 site, 1 recruiting
  • Prince of Wales Hospital, The Chinese University of Hong Kong

    Hong Kong

    Simon SM Ng, MD, (852) 3505 1495, simonng@surgery.cuhk.edu.hk

    Tony WC Mak, MD, (852) 3505 1495, tonymak@surgery.cuhk.edu.hk

    Recruiting

Other trials in China

About this study

Official title: Electroacupuncture Combined With Fast-track Perioperative Program for Reducing Duration of Postoperative Ileus and Hospital Stay After Laparoscopic Colorectal Surgery: A Randomized Controlled Trial

Background: The investigators' previous study demonstrated that electroacupuncture (EA) reduces the duration of postoperative ileus and hospital stay after laparoscopic colorectal surgery within a traditional perioperative care setting. Recent evidence also suggested that a 'fast-track' (FT) perioperative program may help accelerate recovery after colorectal surgery. It is uncertain whether the combination of EA and FT program will result in faster recovery after laparoscopic colorectal surgery when compared with FT program alone.

Objectives: To compare the efficacy of EA combined with FT program versus FT program alone in reducing the duration of postoperative ileus and hospital stay after laparoscopic colorectal surgery

Read more

Design: Prospective randomized trial.

Subjects: 72 consecutive patients undergoing elective laparoscopic resection of colonic and upper rectal cancer without conversion will be recruited.

Interventions: Patients will be randomly allocated to one of the two groups receiving either EA + FT program, or FT program alone.

Outcome measures: Primary outcome: time to defecation. Secondary outcomes: duration of hospital stay, time to resume diet, pain scores, analgesic requirement, morbidity, quality of life, and medical costs.

Conclusions: This study serves as a good example that illustrates an integrated approach in combining Chinese and Western models of health care. It will provide evidence-based clarification of the role of EA in enhancing recovery after laparoscopic colorectal surgery within a FT perioperative care setting. As laparoscopic colorectal surgery has been shown to have a higher direct cost than the open counterpart, a faster postoperative recovery may help reduce the financial burden to the hospital/healthcare system.

Being tested
Electroacupuncture, Fast-track Perioperative program

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ElectroacupunctureProcedure or surgery

    As above

  • Fast-track Perioperative programOther

    As above

Study groups in NCT04090073
Study groupRoleWhat they receive
Electroacupuncture Plus Fast-track Perioperative ProgramExperimentalPatients who are randomized to the intervention arm will receive Electroacupuncture combined with Fast-track program. Each session of Electroacupuncture will last for 20 minutes. The patients will undergo one session of Electroacupuncture daily from day 1 till day 4, or until the time when the primary outcome has occurred, whichever is earlier.
Receives: Procedure: Electroacupuncture; Other: Fast-track Perioperative program
Fast-track Perioperative ProgramActive comparatorPatients who are randomized to the control arm will receive Fast-track program alone.
Receives: Other: Fast-track Perioperative program

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to defecation

    Measured in hours, from the time the laparoscopic surgery ends till the first observed passage of stool.

    Measured: Up to 1 month

Secondary outcomes (12)
  1. Total postoperative hospital stay

    Including hospital stay of patients who are readmitted within 30 days after surgery

    Measured: Up to 1 month

  2. Time of first passing flatus reported by the patients

    Measured: Up to 1 month

  3. Time that the patients tolerated solid diet

    Time that the patients tolerated solid diet (any food that required chewing) without vomiting or experiencing significant nausea 4 hours following the meal

    Measured: Up to 1 month

  4. Time to walk independently

    Measured: Up to 1 month

  5. Pain scores on visual analog scale

    From 0 which implies no pain at all, to 100 which implies the worst pain imaginable, on the first 3 postoperative days

    Measured: Up to 1 month

  6. Postoperative 30-day morbidity

    Defined by the Clavien-Dindo classification of surgical complications

    Measured: Up to 1 month

  7. Incidence rate of adverse events related to electroacupuncture

    Measured: Up to 1 month

  8. Readmission rate

    Measured: Up to 1 month

  9. Quality of life scores measured by Short Form 36 (SF-36) Health Survey at 2 and 4 weeks after surgery

    SF-36 Health Survey is a 36-item, patient-reported survey of patient health. It consists of eight scaled scores, which are the weighted sums of the questions in their section. The eight sections are: vitality, physical functioning, bodily pain, general health perceptions, physical role functioning, emotional role functioning, social role functioning, and mental health. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

    Measured: Up to 1 month

  10. Quality of life scores measured by European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaires at 2 and 4 weeks after surgery

    EORTC QLQ-C30 is a generic questionnaire for assessment of quality of life (QoL) in cancer patients. It includes 30 items, 24 of which are combined to form a global QoL scale, five functional scales (physical, role, emotional, cognitive, and social), and three symptom scales (fatigue, nausea/vomiting, and pain). The other six single items evaluate dyspnea, insomnia, appetite loss, constipation, diarrhea, and financial difficulties. All questionnaires responses and scores will be linearly transformed to a 0-100 scale. A higher score on the global QoL and functional scales represents a higher level of QoL and functioning, whereas a higher score on the symptom scales/items represents a higher degree of symptoms or dysfunction.

    Measured: Up to 1 month

  11. Quality of life measured by European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CR38 questionnaires at 2 and 4 weeks after surgery

    EORTC QLQ-CR38 is a specific questionnaire module specifically designed for assessment of quality of life (QoL) in patients with colorectal cancer. It consists of 38 items covering symptoms and side effects related to different colorectal cancer treatment modalities. The module contains four functional scales (body image, sexual functioning, sexual enjoyment, and future perspective) and eight symptom scales/items (micturition problems, chemotherapy side effects, gastrointestinal tract symptoms, male sexual problems, female sexual problems, defecation problems, stoma-related problems, and weight loss). All questionnaires responses and scores will be linearly transformed to a 0-100 scale. A higher score on the global QoL and functional scales represents a higher level of QoL and functioning, whereas a higher score on the symptom scales/items represents a higher degree of symptoms or dysfunction.

    Measured: Up to 1 month

  12. Direct/indirect medical costs and out-of-hospital economic costs

    Measured: Up to 1 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted16 Sep 2019
  2. Study start1 Oct 2019
  3. Primary completionOct 2020 (estimated)
  4. Study completionOct 2020 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
72 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04090073
Sponsor's protocol ID
CREC 2017.668-T
Status last verified
Sep 2019
First submitted
12 Sep 2019
Last updated
4 Oct 2019
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Electroacupuncture and Fast-track Perioperative program in people with Postoperative Ileus, run by Chinese University of Hong Kong at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 7 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Oct 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Simon SM Ng, MD (+852-35051495, simonng@surgery.cuhk.edu.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to defecation (time frame: Up to 1 month). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Oct 2019.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in